Grace M. Lee MD, MPH; Christine W. Hartmann PhD; Denise Graham BS; William Kassler MD, MPH; Maya Dutta Linn MPH; Sarah Krein PhD, RN; Sanjay Saint MD, MPH; Donald A. Goldmann MD; Scott Fridkin MD; Teresa Horan MPH; John Jernigan MD; Ashish Jha MD, MPH
In 2008, the Centers for Medicare and Medicaid Services (CMS) ceased additional payment for hospitalizations resulting in complications deemed preventable, including several health care-associated infections. We sought to understand the impact of the CMS payment policy on infection prevention efforts.
A national survey of infection preventionists from a random sample of US hospitals was conducted in December 2010.
Eighty-one percent reported increased attention to HAIs targeted by the CMS policy, whereas one-third reported spending less time on nontargeted HAIs. Only 15% reported increased funding for infection control as a result of the CMS policy, whereas most reported stable (77%) funding. Respondents reported faster removal of urinary (71%) and central venous (50%) catheters as a result of the CMS policy, whereas routine urine and blood cultures on admission occurred infrequently (27% and 13%, respectively). Resource shifting (ie, less time spent on nontargeted HAIs) occurred more commonly in large hospitals (odds ratio, 2.3; 95% confidence interval: 1.0-5.1; P = .038) but less often in hospitals where front-line staff were receptive to changes in clinical processes (odds ratio, 0.5; 95% confidence interval: 0.3-0.8; P = .005).
Infection preventionists reported greater hospital attention to preventing targeted HAIs as a result of the CMS nonpayment policy. Whether the increased focus and greater engagement in HAI prevention practices has led to better patient outcomes is unclear.
Grace M. Lee MD, MPH - a,b*
Christine W. Hartmann PhD - c,d
Denise Graham BS - e
William Kassler MD, MPH - f
Maya Dutta Linn MPH - a
Sarah Krein PhD, RN - g
Sanjay Saint MD, MPH - g
Donald A. Goldmann MD - h
Scott Fridkin MD - i
Teresa Horan MPH - i
John Jernigan MD - i
Ashish Jha MD, MPH - j
a - Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
b - Department of Laboratory Medicine and Division of Infectious Diseases, Children's Hospital Boston, Boston, MA
c - Center for Health Quality, Outcomes, and Economic Research, Bedford VA Medical Center, Bedford, MA
d - Department of Health Policy and Management, School of Public Health, Boston University, Boston, MA
e - Association for Professionals in Infection Control and Epidemiology, Washington, DC
f - Centers for Medicare and Medicaid Services, New England Region, Boston, MA
g - Ann Arbor VA Medical Center and University of Michigan Medical School, Ann Arbor, MI
h - Institute for Healthcare Improvement, Cambridge, MA
i - Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, GA
j - Department of Health Policy and Management, Harvard School of Public Health, Boston, MA
Perceived Impact of the Medicare Policy to Adjust Payment for Health Care-associated Infections: Created on May 11th, 2012. Last Modified on May 11th, 2012
Fill in the form below for basic site access (commenting, etc).
Looking for more? Become a CIRI Member...